Market – Page 7

Can Element Biosciences Challenge Illumina in the DNA Sequencing Market?

11 months ago talkbio0Tagged ABC, Anabolism, Avidity Base Chemistry, Aviti sequencer, Biotechnology, Cloudbreak, competition, DNA Sequence, Genomics, High-Throughput Nucleotide Sequencing, Illumina, Market, SBS, Sequence Analysis

Element Biosciences, Illumina, DNA sequencing, next-generation sequencing (NGS), Avidity Base Chemistry (ABC), sequencing by synthesis (SBS), Cloudbreak, Aviti sequencer, genomics, biotechnology, market competition

CDMO Leaders Unite for Turn-key Drug Production

12 months ago talkbio0Tagged CDMOs, competition, Contract Development, end-to-end services, innovation, Lung consolidation, manufacturing organizations, Market, Pharmaceutical Supply Chain, strategic partnerships, Technology

Contract Development and Manufacturing Organizations (CDMOs), pharmaceutical supply chain, advanced therapies, strategic partnerships, end-to-end services, technology innovation, market consolidation, and competitive advantage.

Navigating the Complexities of Adding Rare Disease Products to Your Company’s Portfolio

12 months ago talkbio0Tagged Access, biopharmaceutical development, commercialization, Contract Strategy, Identification (Psychology), Market, Rare disease products, regulatory incentives, Technology, value-based

Rare disease products, biopharmaceutical development, commercialization, market access, patient identification, payer contract strategy, value-based contracting, regulatory incentives, emerging technology.

Biotech Faces a Reckoning: The Challenges and Shifts in Cell Therapies

1 year ago talkbio0Tagged acceptance, Autoimmune Diseases, Cell Therapy, Drug Industry, gene therapy, Manufacture, Market

cell therapy, biotech, gene therapy, autoimmune diseases, manufacturing challenges, market acceptance, pharmaceutical industry

Delaware Court Ruling Allows Zantac Lawsuits to Proceed, GSK Market Cap Plummets by Over $8 Billion

1 year ago talkbio0Tagged Caps, court, Delaware, Drug Industry, financial impact, legal battles, Market, SmithKline Beecham, Zantac lawsuits

Zantac lawsuits, GSK market cap, Delaware court, pharmaceutical industry, legal battles, financial impact

Insmed’s Stocks Skyrocket Following Triumphant Phase III Results for Brensocatib in Bronchiectasis Treatment

1 year ago talkbio0Tagged Approved, brensocatib, Bronchiectasis, Insmed, Lung diseases, Market, New Drug Application, Phase 3 Clinical Trials, surge, United States Food and Drug Administration

Insmed, brensocatib, bronchiectasis, Phase III trial, lung disease, stock surge, New Drug Application, FDA approval, market value

Asahi Kasei Acquires Calliditas Therapeutics for $1.1 Billion to Expand in Rare Disease Market

1 year ago talkbio0Tagged Acquisition (action), Asahi Kasei, Calliditas, IGA Glomerulonephritis, Kidney Diseases, Market, pharmaceutical growth strategy, Tarpeyo

Asahi Kasei, Calliditas Therapeutics, acquisition, rare disease market, kidney disease, Tarpeyo, IgA nephropathy, pharmaceutical growth strategy

AstraZeneca’s Ambitious Vision: Pursuing $80 Billion in Revenue and 20 New Drugs by 2030

1 year ago talkbio0Tagged AstraZeneca, Biotechnology, Drug Development, Drug Industry, expansion, growth strategy, healthcare innovation, Market

AstraZeneca, revenue target, new drugs, 2030, growth strategy, pharmaceutical industry, healthcare innovation, biotechnology, drug development, market expansion.